239 related articles for article (PubMed ID: 33649828)
1. CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.
Guo Q; Liu Y; He Y; Du Y; Zhang G; Yang C; Gao F
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649828
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan delays human amniotic epithelial stem cell senescence by regulating CD44 isoform switch to activate AKT/mTOR signals.
Yu C; Yuan H; Xu Y; Luo Y; Wu ZH; Zhong JJ; Xiao JH
Biomed Pharmacother; 2024 Jan; 170():116100. PubMed ID: 38159379
[TBL] [Abstract][Full Text] [Related]
3. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
4. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
Fang XJ; Jiang H; Zhao XP; Jiang WM
BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation.
Slevin M; Krupinski J; Kumar S; Gaffney J
Lab Invest; 1998 Aug; 78(8):987-1003. PubMed ID: 9714186
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-alpha induces functionally active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-activated protein kinase in lipopolysaccharide-stimulated human monocytic cells.
Gee K; Kozlowski M; Kumar A
J Biol Chem; 2003 Sep; 278(39):37275-87. PubMed ID: 12867430
[TBL] [Abstract][Full Text] [Related]
8. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
9. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family.
Singleton PA; Dudek SM; Ma SF; Garcia JG
J Biol Chem; 2006 Nov; 281(45):34381-93. PubMed ID: 16963454
[TBL] [Abstract][Full Text] [Related]
10. Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways.
Lu CH; Lin CH; Li KJ; Shen CY; Wu CH; Kuo YM; Lin TS; Yu CL; Hsieh SC
Inflammation; 2017 Oct; 40(5):1782-1793. PubMed ID: 28730511
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
Bourguignon LY; Singleton PA; Zhu H; Diedrich F
J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
[TBL] [Abstract][Full Text] [Related]
12. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
[TBL] [Abstract][Full Text] [Related]
13. CD44 variant isoform CD44v10 expression of human melanoma cell lines is upregulated by hyaluronate and correlates with migration.
Yoshinari C; Mizusawa N; Byers HR; Akasaka T
Melanoma Res; 1999 Jun; 9(3):223-31. PubMed ID: 10465577
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β1 induces EMT by the transactivation of epidermal growth factor signaling through HA/CD44 in lung and breast cancer cells.
Li L; Qi L; Liang Z; Song W; Liu Y; Wang Y; Sun B; Zhang B; Cao W
Int J Mol Med; 2015 Jul; 36(1):113-22. PubMed ID: 26005723
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-CD44 interaction promotes growth of decidual stromal cells in human first-trimester pregnancy.
Zhu R; Wang SC; Sun C; Tao Y; Piao HL; Wang XQ; Du MR; Da-Jin Li
PLoS One; 2013; 8(9):e74812. PubMed ID: 24069351
[TBL] [Abstract][Full Text] [Related]
17. HA/CD44 Regulates the T Helper 1 Cells Differentiation by Activating Annexin A1/Akt/mTOR Signaling to Drive the Pathogenesis of EAP.
Chen J; Meng J; Li X; Li X; Liu Y; Jin C; Zhang L; Hao Z; Chen X; Zhang M; Liang C
Front Immunol; 2022; 13():875412. PubMed ID: 35693826
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.
Chen L; Bourguignon LY
Mol Cancer; 2014 Mar; 13():52. PubMed ID: 24606718
[TBL] [Abstract][Full Text] [Related]
19. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
20. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
